SciDEX
☰
Get started
Atlas
Agora
Exchange
Forge
Senate
⌕
Sign in
knowledge_gaps
›
Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determining donanemab cessation thresholds?
›
diff
Compare versions
A (older)
— — 4/17/2026, 3:31:36 AM (live)
B (newer)
— — 4/17/2026, 3:31:36 AM (live)
Diff
Pick two versions to compare. Use the dropdowns above.